SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000926617-21-000007
Filing Date
2021-01-20
Accepted
2021-01-20 17:16:46
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 awh-20210120xs3.htm S-3 377049
2 EX-4.7 awh-20210120xex4_7.htm EX-4.7 553344
3 EX-5.1 awh-20210120xex5_1.htm EX-5.1 65513
4 EX-23.1 awh-20210120xex23_1.htm EX-23.1 5651
5 GRAPHIC awh-20210120xex5_1g001.jpg GRAPHIC 16434
6 GRAPHIC awh-20210120xs3g001.jpg GRAPHIC 33590
  Complete submission text file 0000926617-21-000007.txt   1072066
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252267 | Film No.: 21539512
SIC: 2835 In Vitro & In Vivo Diagnostic Substances